EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Endoscopic ultrasound-guided radiofrequency ablation for large branch-duct intraductal papillary mucinous neoplasms: Safety and efficacy trial

Somashekar G Krishna iD, Erica Park, Jennifer Rath, Zarine Shah, Ahmed Abdelbaki, Stacey Culp, Fadi Hawa, Dan Jones, Wei Chen, Peter Lee, Hamza Shah, Jordan Burlen und 9 weitere

Endoscopy International Open · 21.01.2026 · 14 (CP)

DOI: 10.1055/a-2778-8145 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy International Open, erschienen am 21.01.2026. Verfasst von Somashekar G Krishna und 20 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Hepatology and Nutrition, The Ohio State University Wexner Medical Center, Columbus, United States. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Institute of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) is a nonsurgical treatment option for managing pancreatic lesions. We sought to evaluate the safety and efficacy of EUS-RFA for large (≥4 cm) branch-duct intraductal papillary mucinous neoplasms (BD-IPMNs). Patients with a definitive diagnosis of BD-IPMN who declined or were unfit for surgery underwent EUS-RFA in a single-arm prospective trial. Ablation was performed using a 19G EUS-RFA needle. RFA applications were delivered up to a maximum threshold of 45 seconds or 400 ohms impedance. Safety was assessed using AGREE guidelines. Potential for efficacy was assessed using cyst volume and cyst fluid KRAS GNAS mutations using next-generation sequencing (NGS). Adverse events (AEs) were analyzed per RFA session, while response was analyzed per BD-IPMN. Thirty BD-IPMNs (mean diameter 4.6 ± 1.7 cm; 80% multilocular) in 25 participants (mean age 74.1 ± 8.3 years) underwent 41 EUS-RFA sessions. AEs occurred in 12.2% of procedures (5/41), the majority being AGREE Grade 3A (9.8%, 4/41). During a mean follow-up of 18 ± 5 months, 22 of 28 BD-IPMNs (78.6%) achieved ≥ 50% reduction in cyst volume, and 11 (39.3%) demonstrated complete (≥90%) response. Among 26 BD-IPMNs that revealed KRAS GNAS mutations, follow-up NGS was performed in 17, with 88.2% showing loss of detectable mutations. EUS-RFA in large, predominantly multilocular BD-IPMNs shows promising volumetric efficacy. Safety may be improved through refined energy delivery and technical advances. Molecular response remains exploratory and requires further validation. Long-term studies assessing progression-free outcomes are needed to define its role as an organ-preserving therapeutic option.

Schlagwörter

Stichwörter der Autor:innen

Endoscopic ultrasonographyEndoscopy Upper GI TractIntervention EUSPancreasRFA and ablative methods

Autor:innen und Institutionen

  • Division of Gastroenterology, Hepatology and Nutrition, The Ohio State University Wexner Medical Center, Columbus, United States.
  • Department of Radiology, The Ohio State University Wexner Medical Center, Columbus, United States.
  • Department of Statistics and Biomedical Informatics, The Ohio State University Wexner Medical Center, Columbus, United States.
  • Pathology, The Ohio State University Wexner Medical Center, Columbus, United States.
  • Division of Surgical Oncology, The Ohio State University Wexner Medical Center, Columbus, United States.

ORCID-Profile: Somashekar G Krishna, Mitchell L Ramsey, Timothy Pawlik

Förderung

  • NCI NIH HHS
  • National Institute of Health

Zitieren

APA

Krishna, S. G., Park, E., Rath, J., Shah, Z., Abdelbaki, A., Culp, S., Hawa, F., Jones, D., Chen, W., Lee, P., Shah, H., Burlen, J., Shah, R., Ramsey, M. L., Papachristou, G. I., Cruz-Monserrate, Z., Pawlik, T., Dillhoff, M. E., Cloyd, J. M., …, & Hart, P. A. (2026). Endoscopic ultrasound-guided radiofrequency ablation for large branch-duct intraductal papillary mucinous neoplasms: Safety and efficacy trial. Endoscopy International Open, 14(CP). https://doi.org/10.1055/a-2778-8145

Vancouver

Krishna SG, Park E, Rath J, Shah Z, Abdelbaki A, Culp S, et al. Endoscopic ultrasound-guided radiofrequency ablation for large branch-duct intraductal papillary mucinous neoplasms: Safety and efficacy trial. Endoscopy International Open. 2026;14(CP). doi:10.1055/a-2778-8145

BibTeX
@article{Krishna2026,
  author = {Krishna, Somashekar G and Park, Erica and Rath, Jennifer and Shah, Zarine and Abdelbaki, Ahmed and Culp, Stacey and Hawa, Fadi and Jones, Dan and Chen, Wei and Lee, Peter and Shah, Hamza and Burlen, Jordan and Shah, Raj and Ramsey, Mitchell L and Papachristou, Georgios I and Cruz-Monserrate, Zobeida and Pawlik, Timothy and Dillhoff, Mary E and Cloyd, Jordan M and Tsai, Susan and Hart, Phil A},
  title = {Endoscopic ultrasound-guided radiofrequency ablation for large branch-duct intraductal papillary mucinous neoplasms: Safety and efficacy trial},
  journal = {Endoscopy International Open},
  year = {2026},
  volume = {14},
  number = {CP},
  doi = {10.1055/a-2778-8145}
}
Kostenlos starten →